Sermo Announces Significant Investment from Abry Partners

Partnership accelerates innovation and adoption for data collection
powerhouse and social platform for 800,000+ physicians globally

February 06, 2019 09:00 AM Eastern Standard Time

NEW YORK--(BUSINESS WIRE)--Sermo,
the leading global social platform for physicians and largest healthcare
professional survey company, announced today that it has completed a
recapitalization with Abry
Partners (“Abry”), a leading Boston-based private equity firm. The
investment will allow the company to significantly accelerate its growth
strategy, including the upcoming launch of a new member experience that
will drive impactful peer-to-peer collaboration & discussion amongst
member physicians as well as enhanced automation and tooling for the
healthcare market research industry.

“Sermo is committed to transforming traditional methods of physician
collaboration and healthcare data collection to meet the needs of
today’s fast paced healthcare ecosystems. Using a tech-first approach,
we’ve led Sermo to double-digit growth and transformed the company from
a services provider to a solutions platform,” said Peter Kirk, CEO of
Sermo. “This milestone with Abry recognizes the continued support from
both the financial community as well as our longstanding customers to
continue our mission to connect the global medical community with
industry partners to foster innovation through meaningful insights and
data. With a new leadership team and board of directors, backed by our
unique global platform, we look forward to a successful future.”

Sermo is the most trusted global platform for physicians with over
800,000 members, representing over 90 specialties and subspecialties in
over 150 countries. In 2012, Sermo merged with WorldOne, a leader in
healthcare market research, to form the world’s first global medical
social platform with a tech-first approach to market research ahead of
the digital health revolution.

Sermo clients can expect to see new product launches, differentiated
technologies, physician membership growth in key specialty areas, as
well as an even greater focus on client-centricity as a result of this
investment.

“We’re excited to partner with Sermo as they continue to empower the
healthcare industry with the tools needed to digitally collaborate with
peers and improve patient outcomes,” said John Hunt, Managing Partner at
Abry. “Sermo’s strong revenue growth and increase in users speaks to how
they’re setting a new and improved standard for real-time medical
collaboration and insights, and we look forward to supporting their
continued innovation.”

Sermo will join Abry's portfolio of investments in leading companies
focused on healthcare IT services, insurance services, and business and
information services. Prior healthcare investments include Executive
Health Resources, Healthport, HealthTrans and U.S. Dermatology Partners.

About SermoSermo is a global social platform for physicians
that fosters impactful peer-to-peer collaboration & discussions through
meaningful insights, data, and trends. It is the most trusted global
platform for physicians with over 800,000 fully verified and licensed
physicians across 150 countries. The platform enables doctors to
anonymously talk real-world medicine, review treatment options via our
proprietary Drug Ratings platform, collectively solve patient cases, and
earn honorarium from surveys. Through Sermo’s unique community,
pharmaceutical and healthcare partners can drive physician awareness and
gain deep understanding of brand perceptions to benefit the medical
community at large. To learn more, visit www.sermo.com.

About Abry PartnersAbry is one of the most experienced and
successful sector-focused private equity investment firms in North
America. Since their founding in 1989, the firm has completed over $80
billion of leveraged transactions and other private equity or preferred
equity placements. Currently, the firm manages over $5.0 billion of
capital across their active funds. For more information about Abry,
visit the firm’s website at: www.abry.com.